BIOMAT Database Logo BIOMAT Database Logo

Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors. 2013

Valeria Famiglini, and Antonio Coluccia, and Andrea Brancale, and Sveva Pelliccia, and Giuseppe La Regina, and Romano Silvestri
Istituto Pasteur - Fondazione Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy.

HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) represent one of the most significant classes of drugs for the treatment of AIDS/HIV infection. Over the past two decades several potent arylsulfone-based HIV-1 NNRTIs and related analogs have been developed. This review provides an essential overview of the structure-activity relationships of the arylsulfone-based HIV-1 NNRTIs. Furthermore, structural information useful for the design and development of new sulfur containing NNRTIs with enhanced antiretroviral activity against HIV-1 wild type and clinically relevant drug resistant HIV-1 mutant strains will be discussed.

UI MeSH Term Description Entries
D013450 Sulfones Sulfone
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Valeria Famiglini, and Antonio Coluccia, and Andrea Brancale, and Sveva Pelliccia, and Giuseppe La Regina, and Romano Silvestri
Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors.
February 2006, Current opinion in investigational drugs (London, England : 2000),
Valeria Famiglini, and Antonio Coluccia, and Andrea Brancale, and Sveva Pelliccia, and Giuseppe La Regina, and Romano Silvestri
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1.
June 2003, AIDS (London, England),
Valeria Famiglini, and Antonio Coluccia, and Andrea Brancale, and Sveva Pelliccia, and Giuseppe La Regina, and Romano Silvestri
Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase.
February 1999, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy,
Valeria Famiglini, and Antonio Coluccia, and Andrea Brancale, and Sveva Pelliccia, and Giuseppe La Regina, and Romano Silvestri
QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase.
September 2006, Bioorganic & medicinal chemistry,
Valeria Famiglini, and Antonio Coluccia, and Andrea Brancale, and Sveva Pelliccia, and Giuseppe La Regina, and Romano Silvestri
Mass Spectrometric Characterization of HIV-1 Reverse Transcriptase Interactions with Non-nucleoside Reverse Transcriptase Inhibitors.
January 2016, Biological & pharmaceutical bulletin,
Valeria Famiglini, and Antonio Coluccia, and Andrea Brancale, and Sveva Pelliccia, and Giuseppe La Regina, and Romano Silvestri
[HIV resistance to non-nucleoside reverse transcriptase inhibitors].
August 2006, Virologie (Montrouge, France),
Valeria Famiglini, and Antonio Coluccia, and Andrea Brancale, and Sveva Pelliccia, and Giuseppe La Regina, and Romano Silvestri
HIV nucleoside reverse transcriptase inhibitors.
October 2022, European journal of medicinal chemistry,
Valeria Famiglini, and Antonio Coluccia, and Andrea Brancale, and Sveva Pelliccia, and Giuseppe La Regina, and Romano Silvestri
Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
February 2016, Molecules (Basel, Switzerland),
Valeria Famiglini, and Antonio Coluccia, and Andrea Brancale, and Sveva Pelliccia, and Giuseppe La Regina, and Romano Silvestri
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.
February 2004, Journal of medicinal chemistry,
Valeria Famiglini, and Antonio Coluccia, and Andrea Brancale, and Sveva Pelliccia, and Giuseppe La Regina, and Romano Silvestri
Unbinding Dynamics of Non-Nucleoside Inhibitors from HIV-1 Reverse Transcriptase.
February 2019, The journal of physical chemistry. B,
Copied contents to your clipboard!